Arctic Aurora LifeScience A NOK
Equity fund
1 year
USA
Largest region
Medium
Risk
Cost
Morningstar
Partial
Sustainability
Development
Last 5 years
( ann.)
Description
- Fondets målsetting er å øke verdien av andelseiernes investering gjennom å investere i aksjer globalt innenfor sektorer som farmasi, bioteknologi o.l.
Investment horizon
- Arctic Aurora LifeScience A NOK is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.
Characteristics
- Minimum amount
- Sharpe 3 years
- Price/NAV
04 Jun 2025
- Start date27 Nov 2016
- ISINIE00BYQ7ZL84
Risk
- Medium (4 of 7)
Morningstar rating
- The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.
Sustainability
- SustainabilityPartial
Costs
- Ongoing costs
Includes management fees of 2,00 %
- Platform fee
- Kickback fee
- Annual running costs
- Performance-based fee
Any transaction costs to the manager are not included in the cost overview. These are stated under cost details on the summary page before you purchase the fund. Costs for any currency exchanges are not included.
Allocation
- Stocks 97%Interest 3%
Portfolio
Shows the fund's largest investments.
- Eli Lilly and Co7.0%
- AstraZeneca PLC5.9%
- Novartis AG Registered Shares4.0%
- argenx SE3.3%
- Sanofi SA3.1%
- Daiichi Sankyo Co Ltd ADR2.7%
- Alltrna, Inc -Series B Preferred Stock2.7%
- McKesson Corp2.0%
- Boston Scientific Corp2.0%
- Johnson & Johnson2.0%